Aldosterone Antagonists – Last Man Standing?

Link to article at PubMed

Aldosterone Antagonists - Last Man Standing?

N Engl J Med. 2010 Nov 14;

Authors: Armstrong PW

The transformation of cardiac care over the past half century has been breathtaking to witness. In large part, this transformation is due to the advent of new drugs and devices, improved health care systems, and behavioral modifications such as smoking cessation. Four cardiac medicines developed before 1960 that survived the turn of the millennium are aspirin, digoxin, warfarin, and spironolactone. New competitors threaten the continued longevity of aspirin, the survival of digoxin depends on evidence of its ability to improve exercise tolerance and quality of life in patients with heart failure, and new pretenders for warfarin are here. Remarkably, after . . .

PMID: 21073364 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *